Self-centering guide catheter
US-2017252152-A1 · Sep 7, 2017 · US
US2018353182A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018353182-A1 |
| Application number | US-201715616727-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 7, 2017 |
| Priority date | Jun 7, 2017 |
| Publication date | Dec 13, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure describes interventional devices, systems, and methods for closing a regurgitant gap in a cardiac valve. Interventional devices are configured to be deployed between two previously placed implants or between a previously placed implant and a valve commissure. The interventional devices compress captured leaflet tissue and/or apply a tensioning force along the line of coaptation to assist in closing the gap and reducing regurgitant flow through the gap.
Opening claim text (preview).
1 . An interventional device for tensioning cardiac valve tissue at a targeted gap, the device comprising: a distal section; a proximal section; and an intermediate section disposed between and joining the distal section and the proximal section, wherein the intermediate section has a default width, the intermediate section being laterally compressible from the default width to a compressed width sized for fitting within the targeted gap, and wherein the intermediate section is configured to be biased toward the default width when compressed, the intermediate section thereby providing a tensioning force upon edges of the targeted gap. 2 . The interventional device of claim 1 , wherein the device is configured in size and shape for deployment at a targeted gap measuring about 2 to 8 mm. 3 . The interventional device of claim 1 , wherein the proximal section has a width that is greater than the default width of the intermediate section. 4 . The interventional device of claim 1 , wherein the tissue interventional device is formed as an open wire structure. 5 . The interventional device of claim 4 , wherein the proximal section includes a pair of free ends of the wire structure, the free ends extending distally to form the intermediate section and then closing to form the distal section. 6 . The interventional device of claim 5 , wherein the free ends flare laterally outward relative to the intermediate section. 7 . The interventional device of claim 1 , wherein the interventional device has a substantially flat profile. 8 . The interventional device of claim 1 , wherein the proximal section and the distal section have widths greater than an expanded width of the intermediate section. 9 . The interventional device of claim 1 , further comprising an interior mesh. 10 . The interventional device of claim 1 , wherein the distal section includes a pair of opposing lateral members configured to compress tissue therebetween. 11 . The interventional device of claim 10 , wherein the opposing lateral members each extend to a bend and then extend proximally to form longitudinal members, the longitudinal members defining the intermediate section. 12 . The interventional device of claim 11 , wherein the longitudinal members meet and close to form the proximal section. 13 . The interventional device of claim 10 , wherein the device is formed from a shape-memory material such that free ends, when deployed distally, sweep around proximally to grasp targeted cardiac valve tissue. 14 . An interventional system for tensioning cardiac valve tissue at a targeted gap of a cardiac valve, the system comprising: an interventional tissue tensioning device, the tensioning device comprising: a distal section; a proximal section; and an intermediate section disposed between and joining the distal section and the proximal section, wherein the intermediate section has a default width, the intermediate section being laterally compressible from the default width to a compressed width sized for fitting within the targeted gap, and wherein the intermediate section is configured to be biased toward the default width when compressed, the intermediate section thereby providing a tensioning force upon edges of the targeted gap; and a self-centering delivery catheter, the delivery catheter including a pair of laterally extending fins extending from a distal section of the delivery catheter, the fins enabling alignment of the delivery catheter with a line of coaptation at the targeted gap. 15 . The system of claim 14 , wherein the fins are configured to be intra-procedurally adjustable in width. 16 . The system of claim 15 , wherein the distal section of the delivery catheter includes a pair of skives and a corresponding pair of wires laterally extendable through the skives to form the fins. 17 . The system of claim 16 , wherein the wires extend through a lumen of the delivery catheter such that width of the fins is controllable via translation of the wires. 18 . A method of reducing regurgitation through a cardiac valve by tensioning leaflet tissue at a targeted gap of the cardiac valve, the method comprising: delivering an interventional tissue tensioning device to the targeted gap, the tensioning device comprising: a distal section; a proximal section; and an intermediate section disposed between and joining the distal section and the proximal section, wherein the intermediate section has a default width, the intermediate section being laterally compressible from the default width to a compressed width sized for fitting within the targeted gap, and wherein the intermediate section is configured to be biased toward the default width when compressed, the intermediate section thereby providing a tensioning force upon edges of the targeted gap; and deploying the tensioning device at the targeted gap to tension the leaflet tissue and reduce regurgitant flow through the targeted gap. 19 . The method of claim 18 , wherein the targeted gap is at a mitral valve. 20 . The method of claim 19 , wherein the tensioning device is delivered to the mitral valve from an atrial approach.
for soft tissue, e.g. breast-holding devices · CPC title
for minimally invasive surgery (A61B17/0218, A61B17/0469, A61B17/12013, A61B17/1285, A61B17/29, A61B17/320016 take precedence) · CPC title
Wound clamps {or clips, i.e. not or only partly penetrating the tissue (suture bridges A61B17/0466); Devices for bringing together the edges of a wound} · CPC title
Devices for expanding tissue, e.g. skin tissue (implements for holding wounds open, surgical tractors A61B17/02; implantable mammary prosthesis A61F2/12; dilators A61M29/00) · CPC title
Tissue approximator (A61B2017/1103, A61B17/8866 take precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.